← Back to Search

EnhanceWellness for Disability (EW-D) for Physical Disabilities (EW-D Trial)

N/A
Waitlist Available
Led By Ivan Molton, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 12 months
Awards & highlights

EW-D Trial Summary

This trial will test an intervention to help people with long-term physical disabilities stay active and have a good quality of life.

EW-D Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Self-reported Ability to Participate in Community Activities From Baseline to 6 Months
Secondary outcome measures
Change in Number of Trips Outside the Home Containing "Social" Elements From Baseline to 12 Months
Change in Number of Trips Outside the Home From Baseline to 12 Months
Change in Psychological Resilience From Baseline to 3 Months
+6 more

EW-D Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: EnhanceWellness for Disability (EW-D)Experimental Treatment1 Intervention
Up to 10 sessions of a telephone-based intervention delivered over a six-month period.
Group II: Wellness EducationActive Control1 Intervention
Eight 45-minute sessions of telephone-based wellness education delivered over a six-month period.
Group III: ControlActive Control1 Intervention
Participant continues with their lives as they normally would.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EnhanceWellness for Disability (EW-D)
2019
N/A
~520

Find a Location

Who is running the clinical trial?

National Institute of Nursing Research (NINR)NIH
580 Previous Clinical Trials
10,376,045 Total Patients Enrolled
University of WashingtonLead Sponsor
1,740 Previous Clinical Trials
1,847,154 Total Patients Enrolled
Ivan Molton, PhDPrincipal Investigator - University of Washington
University of Washington
1 Previous Clinical Trials
242 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research venture currently seeking participants?

"The clinicaltrial.gov page for this trial confirms that it is not open to enrollment at the moment; having been initially posted on January 31st 2019 and updated most recently on November 1st 2022. Despite being closed, there are still 40 other studies accepting participants right now."

Answered by AI

Are participants over the age of 45 included in this research investigation?

"This medical study has predetermined that the ideal participants are aged 45 to 64. However, there are 9 trials for minors and 32 studies dedicated to patients above 65 years old."

Answered by AI

What eligibility criteria must be fulfilled to participate in this medical trial?

"This experiment has a target recruitment of 516 disabled participants within the age range of 45 - 64. Qualifying individuals must have an aim for their participation, be literate in English, demonstrate functional disability as determined by the Expanded Functional Disability Scale, and not have previously been involved in EnhanceWellness before turning 40 years old. Additionally, they must also possess the ability to take part via telephone communication."

Answered by AI

Who else is applying?

What state do they live in?
Washington
How old are they?
18 - 65
What site did they apply to?
University of Washington
What portion of applicants met pre-screening criteria?
Met criteria
~84 spots leftby Apr 2025